CLINICAL_TRIALS
trial_result
· 2012-05-04
Clinical Trial Update: Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis [Phase 4]
Summary
A Phase 4 study evaluating tegaserod on gastric emptying in diabetic gastroparesis was terminated. The sponsor listed is Novartis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Gastroparesis, Diabetes | Phase 4 | Status: TERMINATED